SEC Filings TLDR

Robert Gendron, an officer at Vicor Corporation, has exercised stock options for 2,116 shares of common stock on October 23, 2025. The transaction was executed at a market value of $187,649.21. The shares were acquired from the issuer, and the transaction was facilitated by Morgan Stanley Smith Barney LLC Executive Fin...

Nancy Grava, an officer at Vicor Corporation, exercised stock options for 7,032 shares of common stock on October 23, 2025. The transaction was executed at a market value of $639,925.36. The shares were acquired from the issuer, and the payment was made in cash. The transaction was facilitated by Morgan Stanley Smith B...

James Schmidt, an officer of Vicor Corporation, has reported significant securities transactions involving the company's common stock. On October 23, 2025, Schmidt exercised options under a registered plan, acquiring a total of 5,578 shares. Additionally, he sold 5,241 shares in the past three months, generating gross ...

James Colwell, an officer at Valmont Industries Inc, has filed a Form 144 indicating the sale of 375 shares of common stock acquired through restricted stock vesting. The shares were acquired on February 21, 2022, as part of compensation. The sale is expected to occur on October 23, 2025, with an aggregate market value...

Martine Rothblatt, the Founder, Chairperson, and CEO of United Therapeutics Corp, has filed a notice of sale of common stock. The filing details the sale of 4,000 shares on October 23, 2025, with an aggregate market value of $1,688,729.60. Additionally, the filing reports multiple sales of common stock over the past th...

Jeffrey Myers, an officer of Travel and Leisure, has filed a notice of intent to sell 100,000 shares of the company's common stock on October 23, 2025. The shares, which have an aggregate market value of approximately $6,800,000, were acquired through the vesting of restricted stock units at various dates between April...

Kimberly Marshall, an officer of Travel & Leisure, has filed a notice of intent to sell 16,500 shares of common stock, with an aggregate market value of $1,072,500. The sale is planned for October 22, 2025, and will be executed through Merrill Lynch. The securities to be sold were acquired through RSU vesting on March ...

Third Rock Ventures IV, L.P., a 10% stockholder of Tango Therapeutics, Inc., has filed a notice of its intention to sell 477,401 shares of common stock acquired through a pre-IPO investment on July 24, 2017. The shares are expected to be sold on or around October 23, 2025, with an aggregate market value of approximatel...

This SEC Form 144 filing discloses former director Wayne DeVeydt's planned sale of 30,948 common shares of Surgery Partners, Inc. acquired through equity compensation. The filing reveals an extensive pattern of stock dispositions occurring between August and October 2025, with 25 separate transactions totaling approxim...

The filing details the securities transactions of Christopher Gibson, an officer and director of Recursion Pharmaceuticals, Inc. The transactions include the sale of Class A shares acquired as Founders Shares. The filing notes that Gibson plans to sell 100,000 Class A shares on or around October 23, 2025, with an aggre...

David Spector, an officer and director at PennyMac Financial Services, Inc., exercised employee stock options on October 23, 2025, acquiring 71,161 shares of common stock. The transaction was a broker-assisted cashless exercise, with the shares valued at approximately $9,111,993.04. Additionally, Spector sold 5,000 sha...

OrbiMed Private Investments V, LP has filed a Form 144 notice indicating its intention to sell 1,000,000 shares of PMV Pharmaceuticals, Inc. common stock. The shares were acquired during the company's Initial Public Offering on September 29, 2020. The planned sale is expected to occur around October 23, 2025, with an a...

EFSTATHIOS A KOUNINIS, an officer of PEGASYSTEMS INC., has reported the sale of 3,993 shares of common stock on October 23, 2025, through the exercise of options under a registered plan. The aggregate market value of the shares sold was $261,541.50. Additionally, Kouninis has sold shares in the past three months, with ...

On October 23, 2025, Leon Trefler, an officer of Pegasystems Inc., exercised options to acquire 14,865 shares of common stock under a registered plan. The shares were acquired for cash, and the transaction was executed through Morgan Stanley Smith Barney LLC Executive Financial Services. The aggregate market value of t...

Robert Helm, an officer at Ollies Bargain Outlet Holdings, Inc., has filed a Form 144 with the SEC. The filing details the planned sale of 367 common stock units acquired as Restricted Stock Units on October 17, 2025. The aggregate market value of these securities is $44,260.20. Additionally, the filing reports a recen...

The filing details a transaction involving Laura G. Scheland, an affiliate of Oil-Dri Corporation of America. On October 19, 2025, Scheland received a Restricted Stock Award of 7,070 shares of Common Stock as part of equity compensation. Subsequently, on October 22, 2025, Scheland sold 1,700 shares of Common Stock, wit...

Maria Smith, an officer of Oracle Corp, has filed a Form 144 indicating the intent to sell 5,000 shares of Oracle Corp common stock. The shares were acquired through restricted stock vesting on multiple dates between December 2023 and September 2024. The aggregate market value of the shares to be sold is approximately ...

Jeffrey Berg, a director of Oracle Corporation, has filed a notice of planned sale of 49,365 units of Oracle Corporation's common stock. The securities to be sold were acquired through Restricted Stock Units (RSUs) as part of director compensation. The RSUs were granted on various dates from January 7, 2013, to May 31,...

Jen-Hsun Huang, the President and CEO of NVIDIA Corp, has filed a notice of proposed sale of securities under Rule 144. The filing indicates that Huang plans to sell 75,000 shares of NVIDIA common stock. The securities to be sold were acquired through equity compensation, including restricted stock and performance stoc...

John B Hansen, a director of Mueller Industries Inc, has filed a Form 144 indicating the intent to sell 1,000 shares of common stock acquired through vested restricted shares on May 13, 2024. The sale is scheduled for October 23, 2025, with an aggregate market value of $105,207.95. Additionally, Hansen sold 1,000 share...

Gregory Christopher, CEO of Mueller Industries Inc., has filed a Form 144 indicating his plan to sell 300,000 shares of common stock. These shares were acquired on August 1, 2023, as part of restricted stock that has now vested. The approximate sale date is set for October 23, 2025, with an aggregate market value of $3...

Scott C Sanborn, a director and officer of LendingClub Corporation, has filed a Form 144 notice indicating the sale of 30,000 shares of common stock. The shares were acquired as Restricted Stock Units on August 25, 2022. The notice, dated October 23, 2025, also details two recent transactions in the past three months: ...

The filing details the vesting and sale of restricted stock by Frank A StJohn, an officer of Lockheed Martin Corporation. The securities, classified as Common stock, were acquired through a registered plan and were vested on multiple dates: 09/29/2025 (51 shares), 03/31/2025 (56 shares), 06/30/2025 (55 shares), and 02/...

The filing pertains to Carla D'Andre, a former officer of Kingstone Companies, Inc. It details the sale of 5,000 units of common stock, with an aggregate market value of $75,000, scheduled for approximately September 26, 2025. The securities were acquired through stock grants on January 4, 2022, and May 15, 2020. The f...

Mark Iwicki, a director of Kala Bio, Inc., has filed a notice of intent to sell 154,894 shares of common stock acquired through the vesting of Restricted Stock and Performance Shares. The Restricted Stock was acquired on 06/25/2021, and the Performance Shares were acquired on 10/26/2021. The planned sale is scheduled f...